Alicja Urbaniak: Targeting CD148 to Develop New Antithrombotic Therapies
Alicja Urbaniak, Instructor at UAMS – University of Arkansas for Medical Sciences, Full Member Cancer Therapeutics Program at The Winthrop P. Rockefeller Cancer Institute at UAMS, Chair of the Partnerships Committee at American Society for Pharmacology and Experimental Therapeutics – ASPET, shared a post on LinkedIn about a recent article by Lina El Badaoui et al., published in Pharmacology Research and Perspectives, adding:
“The article ‘Targeting CD148 for Antithrombotic Therapy: Functional and Molecular Evaluation of AKB-9778,’ recently published in Pharmacology Research and Perspectives, explores AKB-9778 (razuprotafib) and its potential to inhibit CD148, a protein tyrosine phosphatase involved in platelet activation.
AKB-9778 partially inhibited thrombus formation in an in vitro whole-blood model. Molecular docking and mutagenesis helped identify residues involved in its interaction with CD148.
However, its potency against CD148 was substantially lower than previously reported, highlighting the need for further characterization and optimization.
These findings suggest that AKB-9778 could serve as a starting point for developing more selective and effective CD148 inhibitors.
While this early-stage research offers a promising direction for antithrombotic drug discovery, clinical efficacy and the potential for a lower bleeding risk remain to be established.”
Title: Targeting CD148 for Antithrombotic Therapy: Functional and Molecular Evaluation of AKB-9778
Authors: Lina El Badaoui, Stipo Jurcevic, Yotis A. Senis, Alastair J. Barr

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome